Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NBIX

NEUROCRINE BIOSCIENCES INC

CIK 0000914475 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$152.57
↓ 0.36 (-0.24%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Options

Key stats

Market Cap
$15.51B
P/E Ratio
21.98
EPS
4.81
Dividend Yield
Not covered
52W Position
48%
Beta
0.64

Valuation multiples

Fwd P/E
24.33
PEG
0.49
P/B
4.20
P/S
4.60
EV/Revenue
4.50
ROE
19.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 48%
$122.14$186.12

Latest Financials

2025-12-31 FY
Revenue
$2.86B
Net Income
$478.60M
Total Assets
$4.63B
Free Cash Flow
$748.70M

Recent news